{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"}],"units":"Participants"}],"description":"DLI is used for patients with mixed chimerism following transplant","groups":[{"description":"All patients receive a hematopoietic stem cell transplant using one of two chemotherapy regimens based on disease type","id":"OG000","title":"Hematopoietic Stem Cell Transplantation"}],"paramType":"NUMBER","populationDescription":"36 patients underwent hematopoietic stem cell transplant and therefore were eligible for donor leukocyte infusions for mixed chimerism following transplant","reportingStatus":"POSTED","timeFrame":"Day 100","title":"Number of Patients Requiring the Use of Donor Leukocyte Infusion (DLI) for Early Mixed T-cell Chimerism","type":"SECONDARY","unitOfMeasure":"participants"}